Clinical Trial Update: MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy

View source ↗

Summary

A completed clinical trial from Verinata Health evaluated using maternal blood to diagnose fetal aneuploidy, including trisomies such as Down syndrome, Edwards …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Edwards Syndrome
• Patau Syndrome

Snippet

Sponsor: Verinata Health, Inc. | Conditions: Pregnant Women, Prenatal Care | Status: COMPLETED